Early research (Phase 1)Study completedNCT03207191
What this trial is testing
Trial to Find and Investigate a Safe Dose of F16IL2 and BI 836858 in Patients With AML Relapse After Allogeneic Hematopoietic Stem Cell Transplantation
Who this might be right for
Acute Myeloid Leukemia (AML) Relapse
Philogen S.p.A. 15